Sandbox:skorjian2

Adjuvant therapy

1. Interferon alfa-2a (Roferon-A)
2. Interferon alfa-2b (Intron-A)
3. Peginterferon alfa-2b (Sylatron)

Metastatic or unresectable disease

• Single Agent Chemotherapy

1. Dabrafenib (Tafinlar)
2. Dacarbazine (DTIC)
3. Docetaxel (Taxotere)
4. High-dose (HD) IL-2
5. IL-2 maintenance biotherapy
6. Imatinib (Gleevec)
7. Ipilimumab (Yervoy)
8. Nivolumab (Opdivo)
9. Paclitaxel (Taxol)
10. Pembrolizumab (Keytruda)
11. Temozolomide (Temodar)
12. Trametinib (Mekinist)
13. Vemurafenib (Zelboraf)

• Combination Chemotherapy

1. Paclitaxel nanoparticle albumin-bound + Bevacizumab + Carboplatin (ABC)
2. Carboplatin + Paclitaxel (CP)
3. Carboplatin + Paclitaxel + nanoparticle albumin-bound
4. Carboplatin + Paclitaxe +, Sorafenib
5. Cisplatin + Dacarbazine ± Carmustine
6. Cisplatin + Dacarbazine + IL-2 + IFN alfa-2b ± Carmustine
7. Cisplatin + Paclitaxel + Dacarbazine
8. Cisplatin + Vinblastine + Dacarbazine (CVD)
9. CVD + IL-2 + IFN alfa-2b (sequential biochemotherapy)
10. Temozolomide + Bevacizumab (TB)
11. Dabrafenib + Trametinib
12. Ipilimumab + Dacarbazine
13. Ipilimumab + Nivolumab